Silence Therapeutics’ (SLN) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note ...
Foghorn Therapeutics (NASDAQ:FHTX) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $13.00 ...
Pacira Pharmaceuticals (PCRX) Receives a Hold from Barclays
In a report released today, Balaji Prasad from Barclays maintained a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report), with a ...